Evidence map›Paper›PMID 41522020›Full record

ArticleQuantitative imaging in medicine and surgery2026

Prognostic value of baseline

Chaoran Wang, Keyu Zhang, Guanyun Wang, Wei Wang, Ying Kan, Mingyu Zhang, Jigang Yang

Abstract read
In one paragraph

Article in Quantitative imaging in medicine and surgery, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Chaoran Wang *Nuclear Medicine Department, Beijing Friendship Hospital, Capital Medical University, Beijing, China.
Keyu Zhang *Nuclear Medicine Department, Beijing Friendship Hospital, Capital Medical University, Beijing, China.
Guanyun WangNuclear Medicine Department, Beijing Friendship Hospital, Capital Medical University, Beijing, China.
Wei WangNuclear Medicine Department, Beijing Friendship Hospital, Capital Medical University, Beijing, China.
Ying KanNuclear Medicine Department, Beijing Friendship Hospital, Capital Medical University, Beijing, China.
Mingyu ZhangNuclear Medicine Department, Beijing Friendship Hospital, Capital Medical University, Beijing, China.
Jigang YangNuclear Medicine Department, Beijing Friendship Hospital, Capital Medical University, Beijing, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: Post-transplant lymphoproliferative disorder (PTLD) is a serious complication after pediatric liver transplantation (pLT). Study assessing the prognostic value of pretreatment fluorine-18-fluorodeoxyglucose ( Methods: In total, 42 patients with PTLD after pLT who underwent Results: During a median follow-up period of 638 days (range, 57-2,354 days), 26 patients (61.9%) experienced events defined as PFS, with 25 (59.5%) experiencing recurrence or progression and 1 (2.3%) experiencing mortality attributed to non-PTLD etiology. Univariate Cox regression analysis showed that serum tacrolimus level, morphology, SUVmax, TLG, tMTV, and tTLG were significant predictors of PFS. The results of multivariate analysis revealed that tTLG [hazard ratio (HR) =4.942; 95% confidence interval (CI): 2.142-11.406; P<0.001] were significant independent predictors of PFS. Conclusions: Baseline

Indexed as

fluorine-18-fluorodeoxyglucose positron emission tomography/computed tomography (18F-FDG PET/CT)liver transplantpediatricPost-transplant lymphoproliferative disorder (PTLD)prognosis

Identifiers

PMID41522020
PMCPMC12780601

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.